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The global population is facing a surge in 
metabolic and lifestyle disorders, and the 
contemporary system of medicine is having 
limited efficacy to manage these disorders in 
effective and safe manner. (1-3) Metabolism 
is the breaking down of food to its simpler 
components: proteins, carbohydrates (or 
sugars), and fats. Metabolic disorders occur 
when these normal processes become 
disrupted. Disorders in metabolism can be 
inherited, in which case they are also known 
as inborn errors of metabolism, or they may 
be acquired during your lifetime. (4) Type 2 
Diabetes Mellitus (T2DM) is a cluster of 
abnormal metabolic paradigms with the 
essential feature of hyperglycaemia and is 
dubbed as the disease of “premature ageing”. 
Incidence of T2DM is rising all over the 
world at worrying rate, despite, 
comprehensive and coordinated effects of 
World Health Organization (WHO), 
International Diabetes Federation and Several 
Social Science Agencies. (5) 6.6 % of the 
world population was affected by this disease 
in 2010 with an estimated 285 million carriers 
and the number may become almost double 
(552 million) by 2030. India is facing an even 
grimmer scenario. On the basis of affected 
population, both in terms of percentage and 
numbers India has significantly more patients 
than China and other neighbouring countries 
and is often referred to as the diabetic capital 
of the world. (6) 
Metabolic syndrome is a cluster of 
conditions that occur together, increasing 
your risk of heart disease, stroke and type 2 
diabetes. These conditions include increased 
blood pressure, high blood sugar, excess body 
fat around the waist, and abnormal 
cholesterol or triglyceride levels. Metabolic 
syndrome is closely linked to overweight or 
obesity and inactivity. It's also linked to a 
condition called insulin resistance. Normally, 
your digestive system breaks down the foods 
you eat into sugar. Insulin is a hormone made 
by your pancreas that helps sugar enter your 
cells to be used as fuel. In people with insulin 
resistance, cells don't respond normally to 
insulin and glucose can't enter the cells as 
easily. As a result, your blood sugar levels 
rise even as your body churns out more and 
more insulin to try to lower your blood sugar. 
(7) 
ABSTRACT 
The use of various herbal drugs in India has been widely developed in recent years. Guduchi (Tinospora 
cordifolia) belonging to family Menispermaceae has a tremendous amount of bioactive principles in exploring 
nutraceuticals from natural source. T. cordifolia is considered as an important herbal drug of traditional system of 
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explore and review its role on metabolic disorders. 
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Ayurveda holistic dietary and lifestyle 
management approaches and regimens of 
natural product based medicines offers time-
tested and effective solutions for diabetes and 
related metabolic disorders. (8-10) Ayurveda 
explains metabolic disorders as 
agnivaishamya (problems in digestion, 
absorption). This condition occur due to 
vitiation of digestive fire, this can happen due 
to doshic imbalance a condition occur due to 
blockage in the individual channels of 
metabolism, as a result of this excess or 
improper digestion and absorption occur, and 
results in disease. (11) Tinospora cordifolia 
(Guduchi) is one of the components of 
several traditional formulations with potent 
rejuvenating, immunomodulatory, 
cytoprotective, and antioxidant properties that 
help to manage disordered physiological 
processes of body. (12-14) Tinospora 
cordifolia (Guduchi) composed of so many 
different chemicals constituents that might 
have effect on various system of human body. 
Different experimental or clinical studies 
have shown its effect as antioxidant, 
immunomodulatory, anticancerous, anti-
diabetic, anti hyperlipidemic. So many 
scientific evidences are also available for its 
anti-diabetic potency, anti hyperlipidemic 
properties associated with cardioprotective 
agent on various animal and human models. 
Various classical Ayurvedic texts and 
Nighantu (Ayurvedic materiamedica) have 
described its anti-diabetic usages under 
various names viz. Pramehaghna, 
Pramehahara, Mehaghna and Mehahara. 
(15-19) Ayurvedic Pharmacopoeia of India 
has also cited its antidiabetic utility. (20) 
Tribals of Korkus (Melghat, Maharashtra, 
India) have been using the herb for polyuria, 
diabetes and fever. (21) Various dosage forms 
of Guduchi and wide array of its active, 
natural principles and crude extracts have 
been used in traditional system of medicine 
and have reported anti-diabetic, anti-
hyperlipidemic activity experimentally or 
clinically in numerous scientific journals. 
These constituents directly or indirectly affect 
various metabolic cascades and influence the 
level of glucose. (22) The present review 
highlights the efficacy of Tinospora on 
various metabolic disorders. 
2. Collection of Data 
Published information on Tinospora 
cordifolia were collected from several review 
articles, experimental studies and some cross-
references were collected. Recent 
developments research on role of Tinospora 
cordifolia on various metabolic disorders 
(Table 1), covering all available records and 
articles inPubmed, Scopemed, Dharaand 
other associated databases including fields of 
pharmacological research articles were also 
reviewed. Present review article is restricted 
to the role of plant in metabolic disorders. 
3. Discussion 
Tinospora cordifolia (Family: 
Menispermaceae), a well-known medicinal 
plant of Ayurveda isused in therapeutics as a 
single herb as well as is an essential 
ingredient of several polyherbal Ayurvedic 
formulations. (23, 24) Time-to-time several 
classical dosage forms of Tinospora 
cordifolia are being developed by adopting 
classical pharmaceutical doctrines of 
Ayurveda. (25-28) These dosage forms are 
being used in traditional practice as a 
rejuvenative, health promotive, as well as 
curative medicine in wide range of disorders. 
(29-31)  
Table 1. Pharmacological effects of Tinospora cordifolia in different metabolic disorders 






Root Aqueous  Alloxan-rats 400 mg/kg 3 to 15 
weeks 
Antihyperglycemic. (32) 
Root  Aqueous albino rats  2.5gm/kg, 
5gm/kg, 
6 weeks Lowers the serum 
glucose level. (33) 
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7.5gm/kg 
Root  Alcoholic  Alloxan rats 400mg/kg 4months Lowers the plasma 
glucose level. (34) 
Stem  Alcoholic Alloxan rats 500mg/kg 6weeks Decreased glucose- 6- 
phosphatase, fructose 1, 
6- bi- phosphatase. (35) 












1-100mg - Glucose uptake 
stimulatory activity of 
the lyophilized extracts 
of T. cordifolia viz; 
aqueous, ethanol and 
methanol were evaluated 
for glucose uptake at 
different dosages. (37) 
Root  Alcoholic Alloxan rats 100mg/kg 6 weeks Hypoglycemic effect. 
(38) 
Root  Methanolic Alloxan, 
streptomycin 
induced rat 




Alcoholic  Albino rat 250mg/kg 90days Hypoglycemic effect. 
(40) 
Stem  Alcoholic  Human  125mg/kg, 
250mg/kg 
1 to 2 
weeks 
Non –significant result 
on serum glucose level. 
(41) 











- Hypoglycemiceffect via 
mechanisms of insulin 
releasing and insulin-
mimicking activity. (42) 
Stem Hydoalcoholice
xtraction 












Stem Aqueous  Alloxan 
induced 
diabetic rats 
500 mg/kg 40days  
 
Activity of hexokinase 
enzyme was significantly 
increased whereas 
glucose 6 phosphatase 








400mg/kg 60 days Role against fructose-
induced insulin 
resistance and oxidative 
stress. (45) 
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diabetic Wistar 
rats 











1 day Dose dependent 
hypoglycemic Action 
similar to glibenclamide 
and insulin. (46) 
Leave
s 
Aqueous  Maltose-fed 
rats 
20 mg/kg , 
80 mg/kg 


















Aqueous  Alloxan-rats 
and rabbits 
400 mg/kg - Hypoglycemic effect. 
(50) 
Stem  Aqueous  Human  250 mg/kg 10 days Cardioprotective 
properties of vaso 
dilatation, 
cardiotonicactivity. (51) 
Stem  Aqueous  Human  150 mg/kg, 
300 mg/kg 
28 days Decreases in blood 
pressure and Heart rate. 
(52) 
Stem Alcoholic  Rats  - 7 days Cardioprotective activity 





Stem  Alcoholic Human 500mg 60 days Dyslipidemic features 
declined by 28.6%, 
metabolic syndrome 
decreased by 13.73%. 
(54) 




30 days Hypolipidemic potential. 
(55) 
Root  Aqueous Male albino 
rats 




Stem  Powder  Human 50mg/kg 15 days Decrease in the level of 
Serum Lipoprotein 
Profile. (57) 
Stem  Aqueous  Human  3gm 14 days Antihypertriglyceridemic
activity. (58) 
Leaf  Powder  Human  2gm 60 days Very effective for 
maintaining haemoglobin 
level and total 
erythrocyte count. (59) 
Stem  Powder  Human  6gm 60 days It brings equilibrium of 
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Dosha, Dhatu, Mala in 
the body by bringing 
equilibrium of all the 
vitiated Dhatus also 
MedaDhatu to Sama 
(equilibrium) state. (60) 
Whole 
plant 




Experimental and clinical studies, have 
proven significant role of various extracts 
Tinospora cordifolia as antidiabetic, 
dyslipidemic, cardiotonic, cardioprotective as 
shown in Table 1. Aqueous extract of stem 
obtained from another species of Tinospora- 
‘Tinosporacrispa’ also documented to 
possess the antihyperglycaemic effect is 
probably due to stimulation of insulin release 
via modulation of beta-cell Ca2+ 
concentration. This insulinotropic effect of T. 
crispa is physiological proposes that the 
extracts contain compounds which could be 
used in the treatment of type II diabetes. (62) 
From reference 32- 50, various experimental 
or clinical studies, proved its role as 
hypoglycemic activity by insulin mimicking 
or some other pathway to reduce plasma 
glucose level. A study done in Malaysia, on 
another species of Tinospora cordifolia 
named, Tinosporacrispa extract was taken 
orally by Type 2 (non-insulin-dependent) 
diabetic patients to treat hyperglycaemia. It 
claimed its hypoglycaemic property by 
adding aqueous extract to the drinking water 
of normal and alloxan-diabetic rats. After one 
week of observation, fasting blood glucose 
levels were significantly lower and serum 
insulin levels were significantly higher in 
treated diabetic animals compared to 
untreated diabetic control. This insulinotropic 
action of T. crispa was further investigated in 
vitro using isolated human or rat islets of 
Langerhans and HIT-T15 cells. In static 
incubations with rat islets and HIT-T15 B 
cells, the extract induced a dosage dependent 
stimulation and potentiation of basal and 
glucose-stimulated insulin secretion 
respectively. This insulinotropic effect was 
also evident in perifused human and rat islets 
and HIT-T5 B-cells, the rate of HIT-T15 
glucose utilisation was not affected by 
incubation with T. crispa, suggesting that the 
cells were viable throughout. These are the 
first studies to provide biochemical evidence 
which substantiates the traditional claims for 
an oral hypoglycaemic effect of 
Tinosporacrispa, and which also show that 
the hypoglycaemic effect is associated with 
increased insulin secretion. (61) In Ehrlich 
ascites tumor cells model, water, ethanol and 
methanol extracts of the herb, demonstrated 
the glucose uptake-stimulatory activity. (62) 
5. Cardioprotective 
From table 1, reference 51-53 Tinospora 
cordifolia claimed to have beneficial role on 
cardiac activity. Aqueous and Hydro-
alcoholic extracts of Tinospora cordifolia 
were administered and vital parameters, 
assessment of cardiac profiling were 
performed using cold pressor test (CPT), tilt 
table and platelet aggregation tests. The CPT 
induced arterial stiffness was counteracted by 
treatment with single dose and multiple doses 
of aqueous and hydro-alcoholic extracts 
Tinospora cordifolia. Treatment with single 
doses and multiple doses of aqueous and 
hydro-alcoholic extracts Tinospora cordifolia 
produced increase in cardiac output. (51) 
Tinospora cordifolia is known as an 
adaptogen, as it increases the resistance of the 
body to physical, chemical, and biological 
stress and builds energy, general vitality. It is 
observed that the aqueous extract of 
Tinospora cordifolia when administered on 
daily basis has shown improvement 
(increasing trend) in distance, and max speed, 
VO2 max and muscle power in the presence 
of physical stress. Tinospora cordifolia has 
mainly down-regulated the over activity of 
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sympathetic nervous system. (52) The 
experimental study had done on models of 
myocardial ischemia-reperfusion (I /R) injury 
have shown dose dependent reduction in 
infarct size and in lipid peroxide levels of 
serum. The heart tissues were observed with 
the prior treatment of Tinospora cordifolia 
with various doses. (53) 
6. Hypolipidemic 
From table 1, Tinospora cordifolia have 
proven its hypolipidemic effect on both 
experimental and clinical studies. (54-58) 
Tinospora cordifolia indicated in the 
treatment of diabetes and obesity; both of 
which are associated with each other. It has 
been evaluated for their anti-diabetic and anti-
obese potency. Tinospora cordifolia contains 
multiple bioactives , which were identified to 
interact with multiple proteins involved in the 
pathogenesis of diabetes/obesity, i.e., 
isocolumbin with adiponectin , β-sitosterol 
with cholesteryl ester transfer protein, 
tinocordiside with lamin , berberine with 
JNK1 , β-sitosterol & isocolumbin with 
peroxisome proliferator-activated receptor-γ , 
berberine with suppressor of cytokine 
signaling , isocolumbin with pancreatic α-
amylase, isocolumbin with α-glucosidase, and 
β-sitosterol with aldose reductase.. The study 
suggested the probable modulation in 
multiple pathways in diabetes and obesity. 
(54) The other study indicated that Tinospora 
cordifolia stem extract was able to ameliorate 
the derangements in lipid metabolism which 
were associated with diabetes mellitus in 
streptozotocin induced diabetic rats towards 
normal level. It revealed the usefulness and 
beneficial value of this herb by enhancing 
HDL cholesterol levels and lowering the LDL 
and VLDL cholesterol levels, in treating 
hyperlipidemia. (55) The aqueous extract of 
root of Tinospora cordifolia has 
hypoglycemic effect, which significantly 
reduces the serum liver enzymes and prevents 
the weight gain. (56) Another study done type 
2 diabetic patients, resulted significant 
decrease in the level of fasting blood sugar, 
total cholesterol, β lipoproteins and 
triglycerides. The decrease in lipids and 
apoprotein levels of β lipoproteins was 
accompanied with stimulation of plasma 
lecithin cholesterol acyltransferase (LCAT). 
It showed promising result as an 
hypolipidemic agent. (57) 
Hypertriglyceridemia is an independent risk 
for cardiovascular diseases. Tinospora 
cordifolia is composed of so many alkaloids 
which can lower the triglycerides without side 
effects. A pilot study was done on patients, 
which significantly depleted the levels of 
marker hyperglyceridemia. (58) 
A clinical study was found that, leaf powder 
of Tinospora cordifolia was taken water have 
shown significant increase in haemoglobin 
and total erythrocyte count. It might 
significant role to treat the anaemia. (59) This 
botanical and its several developed 
formulations are thus were explored and 
established having promising potential in the 
management of wide range of metabolic  
7. Conclusion 
In conclusion Tinospora cordifolia could 
prove an excellent substitute for multidrug 
therapy which is currently recommended for 
management of various metabolic disorders. 
Tinospora cordifolia and its various dosage 
forms are reported to possess multi-targeted 
biological properties to manage diabetes, lipid 
disorders and related ailments. Rich bioactive 
phytoconstituents of this plant play a vital 
role in expression of its wide range of 
beneficial effects in metabolic disorders. 
Acknowledgements 
I would like to express my gratitude to 
Himalayan Journal of Health Sciences who 
gave me the opportunity to publish the article. 
Financial Disclosure statement: The author 
received no specific funding for this work. 
Conflict of Interest 
The author declares that there is no conflict 
of interest regarding the publication of this 
article. 
References 
1. Sharma R, Martins N, Chaudhary A, Garg N, 
Sharma V, Kuca K, Nepovimova E, Tuli HS, 
Pritika                                                             Himalayan Journal of Health Sciences                                      ISSN: 2582 - 0737 
© 2021 HJHS Journal                                                                 2021; 6(1) Page 21  
Bishayee A, Chaudhary A, Prajapati PK, et al. 
Adjunct use of honey in diabetes mellitus: A 
consensus or conundrum?. Trends in Food Science 
& Technology. 2020;106:254-274. 
2. Sharma R, Prajapati PK. Rising risk of type 2 
diabetes among inhabitants of Jamnagar, Gujarat: 
A cross-sectional survey. Ayu. 2015; 36:10-7. 
3. Sharma V, Sharma R, Gautam DS, Kuca K, 
Nepovimova E, Martins N. Role of Vacha 
(Acoruscalamus Linn.) in neurological and 
metabolic disorders: Evidence from 
Ethnopharmacology, Phytochemistry, 
Pharmacology and Clinical Study. J Clin Med. 
2020; 9(4):1176. 
4. William C. Lloyd III, Healthgrades Editorial Staff. 
Matabolic Disorder.MD, FACS [Internet]. 2010 




5. Kumar VMD, Khanna P, Karoli R, Mahdi F. A 
review of antioxidant enzymes, oxidative stress, 
lipid profile and lipoprotein constituent in the 
patients of coronary artery disease (CAD) with 
type 2 diabetes mellitus (T2DM). Int J Bioassay. 
2015; 4 (10): 4443-7. 
6. Whiting DR, Guariguata L, Weil C, Shaw J. IDF 
Diabetes Atlas: Global estimates of the prevalence 
of diabetes for 2011 and 2030. Diabetes Res 
ClinPract. 2011; 94: 311-21. 
7. Mayo Foundation for Medical Education and 
Research. [Internet]. 1998-2021 [cited 2021 Jan 




8. Sharma R, Prajapati PK. Diet and lifestyle 
guidelines for diabetes: Evidence based ayurvedic 
perspective. Romanian Journal of Diabetes 
Nutrition and Metabolic Diseases. 
2014;21(4):335-46. 
9. Sharma R, Prajapati PK. Predictive, Preventive 
and Personalized Medicine: Leads From 
Ayurvedic Concept of Prakriti (Human 
Constitution). CurrPharmacol Rep. 2020; 6:441-
450. 
10. Sharma R, Garg N, Verma D, Rathi P, Sharma V, 
Kuca K, Prajapati PK et al. Indian medicinal 
plants as drug leads in neurodegenerative 
disorders. In Nutraceuticals in Brain Health and 
Beyond. Academic Press. p. 31-45. 
https://doi.org/10.1016/B978-0-12-820593-
8.00004-5. 
11.  Kotthahil Ayurveda [Internet]. 2021; 
Hospital.com [cited 2021 Jan 26]. Available from: 
https://www.kottathilayurveda.com/specialities/ge
neral-clinic/metabolic-disorders/ 
12. Sharma R, Kabra A, Rao MM, Prajapati PK. 
Herbal and Holistic solutions for 
Neurodegenerative and Depressive disorders: 
Leads from Ayurveda. Curr. Pharm. Des. 2018; 
27(3): 2597-2608. 
13. Sharma R, Kuca K, Nepovimova E, Kabra A, Rao 
MM, Prajapati PK. Traditional Ayurvedic and 
herbal remedies for Alzheimer's disease from 
bench to bedside. Expert Rev. Neurother. 2019; 
19:359-374. 
14. Sharma R, Martins N. Telomeres, DNA damage 
and ageing: potential leads from 
AyurvedicRasayana (anti-ageing) drugs. J Clin 
Med. 2020; 9(8):2544. 
15. Acharya YT. Siddha Yoga Sangraha. 
Jwaradhikara. 13th ed. Nagpur: Baidyanath 
Ayurveda Bhavan Ltd; 2008. p. 459. 
16. Acharya YT. Sushruta Samhita, Chikitsa Sthana. 
Reprint ed. Ch. 12, Verse 6. Varanasi: 
Chaukhambha Krishanadas Academy; 2004.p. 
459. 
17. Tripathi I, editor. Chakradatta of Chakrapani 
Datta. Prameha Chikitsa. Ch. 35, Ver. 25, Reprint 
edition. Varanasi: Chaukhambha Sanskrit 
Sansthana; 1997.p. 217. 
18. Chunekar KC, Pandey GS. Guduchyadi Varga. 
Bhavaprakash Nighantu. Varanasi: Chaukhamba 
Bharati Academy; 2006.p. 269. 
19. Shastri P, editor. Sharangadhara Samhita of 
Sharangadhara. Madhyam Khanda. Ch. 1, Ver. 7, 
7 ed. Varanasi: Chaukhamba Orientalia 
Prakashan; 2008.p.126. 
20. Anonymous. The Ayurvedic Pharmacopoeia of 
India. Part 1, Vol 1. 1st ed. New Delhi: Govt. of 
India, Ministry of Health and Family Welfare; 
2001.p.53. 
21. Tambekar DH, Khante BS, Chandak BR, Titare 
AS, Boralkar SS, Aghadte SN. Screening of 
antibacterial potentials of some medicinal plants 
from Melghat forest in India. Afr J Tradit 
Complement Altern Med. 2009; 6(3): 228-232. 
22. Sharma R., Hetal A., Prajapati PK. Antidiabetic 
claims of Tinospora Cordifolia (Willd.) Miers: 
critical appraisal and role in therapy. Asian Pacific 
Journal of Tropical Biomedicine. 2015; 5(1): 68-
78. 
23. Sharma R, Amin H. Rasayana Therapy: Ayurvedic 
contribution to improve quality of life. World J. 
Pharmacol. Res. Tech. 2015; 4:23-33.  
24. Sharma R, Martins N, Kuca K, Chaudhary A, 
Kabra A, Rao MM, Prajapati PK et al. 
Chyawanprash A Traditional Indian Bioactive 
Health Supplement. Biomolecules. 2019;13(6): 
161. 
25. Sharma R, Harisha CR, Galib R, Patgiri BJ, 
Prajapati PK. Quantitative estimation of Satva 
extracted from different stem sizes of Guduchi 
(Tinospora Cordifolia (Willd.) Miers. J Pharm 
SciInnov. 2012; 1(1):38-40. 
26. Sharma R, Prajapati PK. Liquid media’s in 
BhavanaSamskara: A pharmaceutico-therapeutic 
prospect. J Phytopharm. 2015; 4:49-57. 
Pritika                                                             Himalayan Journal of Health Sciences                                      ISSN: 2582 - 0737 
© 2021 HJHS Journal                                                                 2021; 6(1) Page 22  
27. Sharma R, Galib R, Prajapati PK. Validation of 
standard manufacturing procedure of Guduchi 
Ghana [dried aqueous extract of Tinospora 
Cordifolia (Willd.) Miers] and its tablets. 
Ayurpharm. Int J Ayurveda Allied Sci. 2013; 
2:224-32. 
28. Sharma R, Amin H, Galib, Prajapati PK. 
Validation of standard manufacturing procedure of 
Guducisattva (aqueous extract of Tinospora 
Cordifolia (Willd) Miers) and its tablets. AncSci 
Life. 2013; 33:27-34. 
29. Sharma R, Hazra J, Prajapati PK. 
Nanophytomedicines: A Novel Approach to 
Improve Drug Delivery and Pharmacokinetics of 
Herbal Medicine. Bio Bull. 2017; 3(1):132-5. 
30. Prajapat R, Sharma R, Prajapati PK. Physico-
chemical evaluation of guduchyadikwatha for 
instant use: An ayurvedic herbal formulation. 
Journal of Pharmaceutical Research International. 
2014; 2599-613. 
31. Sharma R, Galib R, Prajapati PK. Antimicrobial 
evaluation of Svarasa Bhavita Guduchi Churna 
(levigated powder of Tinospora Cordifolia 
(Willd.) Miers with its juice). Ayurscientifica. 
2017; 1(1):25-30.  
32. Grover JK, Vats V, Rathi SS. Anti-hyperglycemic 
effect of Eugenia jambolana and Tinospora 
Cordifolia in experimental diabetes and their 
effects on key metabolic enzymes involved in 
carbohydrate metabolism. J Ethnopharmacol. 
2000; 73(3):461-470. 
33. Stanely P, Prince M, Menon VP. Hypoglycaemic 
and other related actions of Tinospora Cordifolia 
roots in alloxan-induced diabetic rats. J 
Ethnopharmacol. 2000; 70(1):9-15. 
34. Rathi SS, Grover JK, Vikrant V, Biswas NR. 
Prevention of experimental diabetic cataract by 
Indian Ayurvedic plant extracts. Phytother Res. 
2002; 16(8):774-777. 
35. Sivakumar V., Dhana RM.S. Hypoglycemic and 
Antioxidant Activity of Tinospora Cordifolia in 
Experimental Diabetes. International Journal of 
Pharmaceutical Sciences and Research. 2011; 
2(3):608-613. 
36. Kinkar SB, Gopal PK. Antidibetic activity of 
Tinospora Cordifolia (Fam: Menispermaceae) in 
alloxen treated albino rat. Applied Research 
Journal. 2015;1(5):316-319. 
37. Joladarashi D., Chilkunda ND, &Salimath PV. 
Glucose uptake stimulatory activity of Tinospora 
Cordifolia stem extracts in Ehrlich ascites tumor 
cell model system. Journal of Food Science and 
Technology. 2014; 51(1),178-182. 
38. Prince PSM, Kamalakkannan N, Menon VP. 
Restoration of antioxidants by ethanolic Tinospora 
cordifolia in alloxan-induced diabetic Wistar rats. 
Acta Pol Pharm. 2004;61:283-287. 
39. Dhulia I, Parcha V, Pant G, Kumar D, Maithani A. 
Antihyperglycemic effect of methanolic extract of 
Tinospora cordifolia (Willd.) stem on 
experimentally induced diabetic rats. J Pharm Res. 
2011; 4(8):2828- 2830. 
40. Rajalakshmi M, Eliza J, EdelPC, Nirmala A, 
Daisy P. Anti-diabetic properties of Tinospora 
cordifolia stem extracts on streptozotocin- induced 
diabetic rats. African Journal of Pharmacy and 
Pharmacology. 2009 May; 3(5):171-180. 
41. Klangjareonchai T, Roongpisuthipong C. The 
Effect of Tinospora crispa on Serum Glucose and 
Insulin Levels in Patients with Type 2 Diabetes 
Mellitus. Journal of Biomedicine and 
Biotechnology Volume 2012, Article ID 808762, 
4 pages. 
42. Patel MB, Mishra S. Hypoglycemic activity of 
alkaloidal fraction of Tinospora cordifolia. 
Phytomedicine. 2011;18:1045-1052. 
43. Sangeetha MK, Balaji Raghavendran HR, 
Gayathri V, Vasanthi HR. Tinospora cordifolia 
attenuates oxidative stress and distorted 
carbohydrate metabolism in experimentally 
induced type 2 diabetes in rats. J Nat Med. 
2011;65:544-550. 
44. Sivakumar V, Mohamed SA. Hypoglycemic 
activity of Tinospora cordifolia in Alloxan 
induced diabetic rats. The Bioscan. 2009;4:75-78. 
45. Reddy SS, Ramatholisamma P, Karuna R, 
Saralakumari D. Preventive effect of 
Tinosporacordifolia against high-fructose 
dietinduced insulin resistance and oxidative stress 
in male Wistar rats. Food ChemToxicol. 
2009;47(9):2224-29. 
46. Wadood N, Wadood A, Shah SA. Effect of 
Tinospora cordifolia on blood glucose and total 
lipid levels of normal and alloxan-diabetic rabbits. 
Planta Med. 1992;58(2):131-136. 
47. Sengupta S, Mukherjee A, Goswami R, Basu S. 
Hypoglycemic activity of the antioxidant 
saponarin, characterized as alphaglucosidase 
inhibitor present in Tinospora cordifolia. J 
Enzyme Inhib Med Chem. 2009;24:684-690. 
48. Grover JK, Rathi SS, Vats V. Amelioration of 
experimental diabetic neuropathy and gastropathy 
in rats following oral administration of plants 
(Eugenia jambolana, Mucurnapruriens and 
Tinospora cordifolia) extracts. Indian J ExpBiol. 
2002;40:273-276. 
49. Grover JK, Vats V, Rathi SS, Dawar R. 
Traditional Indian anti-diabetic plants attenuate 
progression of renal damage in streptozotocin 
induced diabetic mice. J Ethnopharmacol. 
2001;76:233-238. 
50. Raghunathan K, Sharma PV. The aqueous extract 
of T. cordifolia caused reduction of blood sugar in 
alloxan induced hyperglycemic rats and rabbits. J 
Res Ind Med. 1969; 3:203-209. 
51. Pingali U, Kishore KK, Fatima N, Chandrasekhar 
N, Sravanthi IV. Evaluation of Cardiovascular and 
Pharmacodynamic Effects of Single and Multiple 
Doses of Aqueous and HydroAlcoholic Extracts of 
Tinospora cordifolia in Healthy Human Male 
Pritika                                                             Himalayan Journal of Health Sciences                                      ISSN: 2582 - 0737 
© 2021 HJHS Journal                                                                 2021; 6(1) Page 23  
Subjects. American Journal of Phytomedicine and 
Clinical Therapeutics. 
52. Salve Bharat A, Tripathi RK, Petare AU, Raut 
AK, Rege NN. Effect of Tinospora cordifolia on 
physical and cardiovascular performance induced 
by physical stress in healthy human volunteers. 
Ayu. 2015 Jul-Sep;36(3):265-70. 
53. Rao PR, Kumar VK, Viswanath RK, Subbaraju 
GV. Cardioprotective activity of alcoholic extract 
of Tinospora cordifolia in ischemia reperfusion 
induced myocardial infarction in rats. Biol Pharm 
Bull. 2005;28:2319-2322. 
54. Mandar, B.K., Khanal, P., Patil, B.M. et al. In 
silico analysis of phytoconstituents from 
Tinospora cordifolia with targets related to 
diabetes and obesity. In Silico Pharmacol. 
2021;9:3 
https://doi.org/10.1007/s40203-020-00063-w 
55. Nagaraja PK, Kammar KF, Sheela DR. Efficacy 
of Tinospora cordifolia (Willd.) extracts on blood 
lipid profile in streptozotocin diabetic rats. Is it 
beneficial to the heart? Biomed Res. 2008;19:92-
96. 
56. Sparshadeep EM, NayakRP, Kavana GV, RaiM. 
Evaluation of hypolipidemic effect of Tinospora 
cordifolia in cholesterol diet induced 
hyperlipidemia in rats. International Journal of 
Basic & Clinical Pharmacology. 2016 Aug; 
5(4):1286-92. 
57. Kumar V, Mahdi F, Singh R, Mahdi AA, Singh 
RK. A clinical trial to assess the antidiabetic, 
antidyslipidemic and antioxidant activities of 
Tinospora cordifolia in management of type - 2 
diabetes mellitus. International Journal of 
Pharmaceutical Sciences and Research. 
2016;7(2):757-64. 
58. Shirolkar A, Yadav A, Mandal TK, Dabur R. 
Intervention of Ayurvedic drug Tinospora 
cordifolia attenuates the metabolic alterations in 
hypertriglyceridemia: a pilot clinical trial. Journal 
of Diabetes and metabolic disorders; 2020. 
59. Tripathi N, Choudhary A. Magical effects of 
Tinospora cordifolia leaf powder supplementation 
on erythrocyte count and haemoglobin levels of 
anemic obese women. World Journal of 
Pharmaceutical Research. 3(2):2585-89. 
60. Sharma M, Murthy AR, Rath SK, Sharma U. 
Clinical study on Guduchi (Tinospora cordifolia 
willd.) And Mustak (Cyperus Rotunduslinn.) in 
sthoulyawith special reference to overweight. 
Journal of Pharmaceutical and Scientific 
Innovation. 2019; 8(6). 
61. Noor H, Hammonds P, Sutton R, Ashcroft SJ. The 
hypoglycaemic and insulinotropic activity of 
Tinosporacrispa: studies with human and rat islets 
and HIT-T15 B cells. J Ethnopharmacol.1998 
Aug;62(1):7-13. 
62. Noor H, Ashcroft SJ. Pharmacological 
characterisation of the antihyperglycaemic 
properties of Tinospora crispa extract. J 
Ethnopharmacol. 1998;62(1):7-13. 
63. Sharma R, Kumar V, Ashok BK, Galib R, 
Prajapati PK, Ravishankar B. Evaluation of 
hypoglycaemic and anti-hyperglycaemic activities 
of Guduchi Ghana in Swiss albino mice. Int J 
Green Pharm. 2013;7:145-8.  
64. Sharma R, Kumar V, Ashok BK, Galib R, 
Prajapati PK, Ravishankar B. Hypoglycemic and 
anti-hyperglycemic activity of Guduchi Satva in 
experimental animals. AYU. 2014;4:217-20.  
65. Sharma R, Shukla VJ, Ravishankar B, Prajapati 
PK. The effect of two different dosage forms of 
Guduchi i.e. Satva and Ghana WSR 
antihyperglycemic effect on madhumeha 
(NIDDM) [dissertation], Gujarat Ayurved 
University, IPGT and RA, Jamnagar; 2012:132-3. 
